4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-064271
Senior VP, Chief Pharma Dev. sold 1,036 shares at $231.34 ($239,668)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-05-21 | Sale | −1,036 | $231.34 | $239,668 | 5,500 | D |
| Open-market sales · 1,036 sh · avg $231.34 · $239,668 | |||||||
Loading xslF345X05/ownership.xml…